Business Description
Founded in 1929 and based in Paris, France, Ipsen is a global biopharmaceutical company focused on treating cancer, rare diseases, and neurological conditions across North America, Europe, and beyond. The company markets several established medicines targeting conditions such as prostate cancer, neuroendocrine tumors, and movement disorders, while also advancing a broad pipeline of new treatments at various stages of clinical development. Among its most notable pipeline programs are therapies aimed at pediatric brain tumors, blood cancers, and ultra-rare bone diseases.
